Resultado de búsqueda
Biogen. Careers. Students & Graduates. Enrich Your Education. We welcome students and graduates to contribute their passion and creativity to our mission. Our programs include summer internships, six-month co-ops, MBA opportunities, post-doctoral programs, and both PharmD and Ph.D. Fellowships. These opportunities offer invaluable experience in ...
Job Filter. Receive up-to-the-minute job openings tailored just for you. Information for. Medical Professionals. Investors. Media. Job Seekers. Get in touch.
31 de ene. de 2024 · Biogen will focus on LEQEMBI® (lecanemab-irmb) with Eisai and advancing potential new modalities to address the multiple pathologies of the disease and unmet patient needs. A plan for patients participating in clinical trials or on commercially available treatment is in place. Patients with questions are encouraged to call our patient support ...
25 de abr. de 2023 · Biogen has applied important learnings to its portfolio of assets for genetic and other forms of ALS, with the goal of increasing the probability of bringing a potential therapy to patients in need. These applied learnings include evaluating genetically validated targets in defined patient populations, pursuing the most appropriate modality for each target and employing sensitive clinical ...
在百健（Biogen） ，我們的使命很明確：我們是創新科學的先驅，研發和推動新藥來扭轉病患的生命。 百健（Biogen） 是一家領先全球的生技公司，專注在複雜且嚴重的疾病，我們正在研究與發展的領域涵蓋神經學、神經精神病學、免疫學以及罕見疾病，將持續透過用科學造福人群的使命，推動創造 ...
Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis. May 14, 2024. Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status.
Biogen. Science & Innovation. We work in disease areas with some of the greatest unmet need. We work relentlessly, knowing that bold new possibilities await discovery. As a leading global biotechnology company, we work toward those once-in-a-lifetime moments that could become a historic point in our pursuit of innovative treatments. Learn more.
